Back to Search Start Over

Can environmental regulations and R&D subsidies promote GTFP in pharmaceutical industry? Evidence from Chinese provincial panel data.

Authors :
Yang YD
Source :
Frontiers in public health [Front Public Health] 2022 Sep 26; Vol. 10, pp. 1018968. Date of Electronic Publication: 2022 Sep 26 (Print Publication: 2022).
Publication Year :
2022

Abstract

Based on the panel data of 30 provinces in China's pharmaceutical industry from 2000 to 2019, this paper proposes to combine the super efficiency SBM model and GML productivity index to calculate the static and dynamic green total factor productivity (GTFP). Then, the Tobit model is adopted for regression analysis on how environmental regulations, government R&D subsidies, and their cross-terms affect the GTFP. Findings suggest that: (1) Static analysis reveals that the GTFP in China's pharmaceutical industry is markedly different among provinces and regions, and the dynamic analysis shows an upward trend from 2000 to 2019. (2) The GTFP of the pharmaceutical industry and environmental rules are connected in a U-shape. The government R&D subsidies to GTFP are positive and significant, and with the expansion of government R&D subsidies, the promotion effect of environmental regulations on GTFP is enhanced. Therefore, it is necessary to set up differentiated environmental regulations systems in different provinces and increase R&D subsidies to promote the pharmaceutical industry's green development.<br />Competing Interests: The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2022 Yang.)

Subjects

Subjects :
China
Drug Industry
Efficiency

Details

Language :
English
ISSN :
2296-2565
Volume :
10
Database :
MEDLINE
Journal :
Frontiers in public health
Publication Type :
Academic Journal
Accession number :
36225766
Full Text :
https://doi.org/10.3389/fpubh.2022.1018968